Compugen Ltd. ROA Ratio 2011-2026 | CGEN

Annual ROA Ratio Compugen Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
22.57	-12.38	-15.46	-35.78	-25.88	-21.47	-50.85	-42.5	-95.66	-44.29	-20.3	-9.65	-24.83	-47.15	-41.26

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
22.57	-95.66	-30.99

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Altimmune ALT	-31.47	$ 3.41	2.1 %	$ 300 M	USA
Amgen AMGN	8.51	$ 350.17	0.68 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	6.02	$ 19.57	0.36 %	$ 915 M	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-35.36	$ 217.82	-1.83 %	$ 5 B	Danmark
Autolus Therapeutics plc AUTL	-28.19	$ 1.4	1.82 %	$ 357 M	Britain
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	-10.92	$ 2.64	1.15 %	$ 16.6 M	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	-21.14	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-123.72	-	-10.17 %	$ 12.2 K	USA
Benitec Biopharma BNTC	-8.84	$ 11.0	0.18 %	$ 453 M	USA
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-11.27	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-101.11	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	-13.29	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Avenue Therapeutics ATXI	-437.72	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-225.71	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	65.04	$ 1.58	3.62 %	$ 185 M	USA
Cellectis S.A. CLLS	-32.74	$ 3.35	0.3 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	-49.04	$ 12.83	0.71 %	$ 773 M	USA
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-177.73	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-94.17	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-30.95	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	-249.92	-	-74.18 %	$ 955 K	USA
CorMedix CRMD	19.74	$ 6.29	0.64 %	$ 453 K	USA
CytomX Therapeutics CTMX	-11.46	$ 4.41	-1.01 %	$ 608 M	USA
Checkpoint Therapeutics CKPT	-752.78	-	-	$ 169 M	USA
Clovis Oncology CLVS	-55.94	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	-30.77	$ 20.92	3.69 %	$ 3.44 B	USA
Dyadic International DYAI	-82.68	$ 0.89	-5.85 %	$ 25.6 M	USA
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-50.45	$ 4.26	0.47 %	$ 707 M	Canada
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA